Saframycin E
Saframycin E has the effect of anti-Gram-positive bacteria. Saframycin B also has weak activity against mycobacteria[1].
Product Specifications
CAS Number
66082-31-3
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
CC(C(NC[C@H]1C2=C(C(C(C)=C(OC)C2=O)=O)C[C@@]3([H])[C@@]4([H])C5=C(O)C(OC)=C(C)C(O)=C5[C@H](O)[C@@](N4C)([H])CN31)=O)=O
Molecular Formula
C28H33N3O9
Molecular Weight
555.58
References & Citations
[1]N Saito, et al. Synthesis of saframycins. X. Transformation of (-) -saframycin A to (-) -saframycin Mx type compound with the structure proposed for saframycin E. Chem Pharm Bull (Tokyo) . 1995 May;43 (5) :777-82.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1478745-01 0.02 mg (E-Coli)
Recombinant Salmonella choleraesuis Phosphoglucosamine mutase (glmM)
Sign In for Pricing
View Details MBS1478745-02 0.02 mg (Yeast)
Recombinant Salmonella choleraesuis Phosphoglucosamine mutase (glmM)
Sign In for Pricing
View Details MBS1478745-03 0.1 mg (E-Coli)
Recombinant Salmonella choleraesuis Phosphoglucosamine mutase (glmM)
Sign In for Pricing
View Details MBS1478745-04 0.1 mg (Yeast)
Recombinant Salmonella choleraesuis Phosphoglucosamine mutase (glmM)
Sign In for Pricing
View Details MBS1478745-05 0.02 mg (Baculovirus)
Recombinant Salmonella choleraesuis Phosphoglucosamine mutase (glmM)
Sign In for Pricing
View Details